-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
March 20, 2021 - Definition Negative Cohort Definition Age: Mean (SD) Years or Median (IQR) Race Stratified, N (%) Male Sex/Gender … ages NR for both care homes NR n/N (%)
Care home A: 13/46 (26.3)
Care home L: 21/57 (36.8*)
Staff gender … Geneva and their households Children 5–12 years old Ab+ Two negative serology propensity matched (age, gender
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
October 01, 2022 - setting, study design, study dates, sample size, follow-up duration, patient characteristics (age,
gender … N=8307
OMT: N=8136
Diagnosis: chronic coronary
syndrome
Age: Mean range: 60 to 80
years
Gender … N=5,575
OMT: N=5,569
Diagnosis: stable obstructive
CAD
Age: Mean range: 62 to 65
years
Gender … Gender: Range: 69% to 95%
male
Intervention/Comparators:
PCI vs. MT
CABG vs. MT
PCI vs. … OMT: N=826
Diagnosis: coronary CTO
Age: Mean range: 57 to 65
years
Gender: Range: 82% to 89%
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
February 07, 2025 - Synthes
is
“We do not anticipate
social determinants of
health (e.g., race and
ethnicity, gender … of interest”
These terms
were removed to
comply with
Executive Order
Defending
Women from
Gender … Plus framework (which
includes Place;
Race/ethnicity/culture/la
nguage; Occupation; Out
of Work, Gender … provide clarity”
These terms
were removed to
comply with
Executive Order
Defending
Women from
Gender
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amendment.pdf
May 02, 2025 - Data
Synthesis
“We do not anticipate
social determinants of
health (e.g., race and
ethnicity, gender … of
interest”
These terms
were removed to
comply with
Executive Order
Defending
Women from
Gender … PROGRESS-Plus
framework (which
includes Place;
Race/ethnicity/culture/la
nguage; Occupation;
Out of Work, Gender … provide
clarity”
These terms
were removed to
comply with
Executive Order
Defending
Women from
Gender
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
May 29, 2025 - Differences in gender and age between the study population and the general population
Use of a surrogate
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
May 29, 2025 - Differences in gender and age between the study population and the general population
Use of a surrogate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
January 01, 2013 - therapies compare in different populations (e.g., different depressive diagnoses, disease severity, age, gender … The effects of baseline severity,
previous treatment failure, age, gender, and
race were not sufficiently … therapies compare in different populations (e.g., different depressive diagnoses, disease severity, age, gender … The
effects
of
baseline
severity,
previous
treatment
failure,
age,
gender
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
May 01, 2011 - research studies are needed that are large
enough for statistical analysis of subgroups (by age,
gender
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
January 01, 2013 - Do the effect estimates of clinical cardiovascular outcomes vary by age, ethnicity, gender, or health … Do the effect estimates of intermediate cardiovascular outcomes vary by age, ethnicity, gender, or health … Do the effect estimates of pharmacokinetic outcomes vary by age, ethnicity, gender, or health status? … Do the effect estimates of clinical cardiovascular outcomes vary by age, ethnicity, gender, or health … Do the effect estimates of pharmacokinetic outcomes vary by age, ethnicity, gender, or health status?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-275-people-with-disabilities-disposition-comments.pdf
September 16, 2024 - descriptions generally do not note
where the studies were conducted or the
characteristics (including gender … your language choices around disability, it may be
worth considering adding a footnote about sex and
gender … At a minimum, an acknowledgement in a
We have made edits to change gender-specific terms (e.g.,
“women … with disabilities”) to gender-neutral terms (e.g. … We have also added a footnote to Table 1
indicating that we have used gender-specific terms (e.g.,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
January 01, 2022 - Pain intensity index (0-100 scale; converted to 0-10 scale)
4.4 (SD 1.46) Propensity matched on age, gender … B
Average 24-h PIX (0 to 100 VAS): 43.3 (14.0) vs. 43.1 (14.0)
Overall mean: 43.2 (SD 14.0) Age, gender
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
January 01, 2022 - Pain intensity index (0-100 scale; converted to 0-10 scale)
4.4 (SD 1.46) Propensity matched on age, gender … B
Average 24-h PIX (0 to 100 VAS): 43.3 (14.0) vs. 43.1 (14.0)
Overall mean: 43.2 (SD 14.0) Age, gender
-
effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
August 27, 2012 - Process factors
– Health-Care Setting
– Physician interactions
Personal factors
– Age, gender
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
January 01, 2024 - ]): A: 4.13 (2.93-5.65); B: 3.96 (1.77-5.45); C: 4.56 (3.27-6.20) Univariate analysis for age, BMI, gender … Pain intensity index (0-100 scale; converted to 0-10 scale)
4.4 (SD 1.46) Propensity matched on age, gender … B
Average 24-h PIX (0 to 100 VAS): 43.3 (14.0) vs. 43.1 (14.0)
Overall mean: 43.2 (SD 14.0) Age, gender
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
February 01, 2009 - Age, gender, and race.
Comorbidities. … % of Conventional % of Atypical
APM Users APM Users
Age (mean): 83.2 83.5
Gender … 1.20 (1.03, 1.39) 1.10 (0.98, 1.24) 1.06 (0.96, 1.17)
*Controlled for calendar year, age, gender
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear-surveillance-140925.pdf
February 01, 2014 - 1
• Key question # 6: Which demographic (e.g., age, gender, ethnicity, comorbidities … fatty infiltration (Goutallier 1.3 vs 0.3, p=0.01).33 One
Signal
A third cohort study found that gender … repair
the failure rate was
significantly higher
in patients with
lower BMD
(p<0.001); female
gender … Key Question 6: Which demographic (e.g., age, gender, ethnicity, comorbidities, workers‘ compensation … aggravation, smoking,
diabetes mellitus
female gender (P = .03); larger
tear size (P<.001); higher
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
June 12, 2012 - There are numerous gender
comparisons of prognosis in very large registries often including more
than … Also, based on my knowledge of the
literature, there is no known gender difference with respect to any … recommended methods, such as Diamond-
Forrester or CASS study criteria (where pain
type,
age, and gender … No other gender differences were
noted in diagnostic accuracy. … Gender-specific issues such as symptom and test-related office visits,
downstream testing that can be
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - characteristics of interest include, but are not limited to, age
(prepubertal, pubertal, postpubertal), gender … In five
controlled trials, rhGH therapy did not
improve sexual maturation regardless of
gender. … In one controlled trial, mean Tanner
stage improved regardless of gender, and in
an analysis of three … New Evidence:
Gender:
While trials were conducted predominantly in
males, the impact … of gender on outcomes of
rhGH therapy could be evaluated in one
pooled analysis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
November 01, 2010 - significantly in
subgroups of people who are easily identified by one or more of the following factors:
age, gender … CVD]), vascular risk
factors (e.g., hypertension, diabetes, obesity, hyperlipidemia, smoking, male
gender … CVD), vascular
risk factors (e.g., hypertension, diabetes, obesity, hyperlipidemia, smoking, male
gender … CVD), vascular
risk factors (e.g., hypertension, diabetes, obesity, hyperlipidemia, smoking, male
gender
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - In patients with cystic fibrosis and relevant subgroups based on gender, age, baseline clinical status … In patients with cystic fibrosis and relevant subgroups based on gender, age, baseline clinical status … characteristics of interest include, but are not limited to, age (prepubertal, pubertal, postpubertal); gender … characteristics of interest include, but are not limited to, age (prepubertal, pubertal, postpubertal); gender